Cascade Financial Partners, LLC
Source: SEC Form 13F · as of Mar 2026Cascade Financial Partners, LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $225.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$225.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 236,682 | $217.7M |
| JNJJOHNSON & JOHNSON | 8,112 | $2.0M |
| MRKMerck & Co., Inc. | 14,666 | $1.8M |
| PFEPFIZER INC | 26,509 | $744K |
| NVSNovartis AG | 4,733 | $723K |
| ABBVAbbVie Inc. | 2,476 | $539K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,652 | $447K |
| AMGNAMGEN INC | 1,264 | $445K |
| GILDGILEAD SCIENCES, INC. | 1,715 | $239K |
| PMPhilip Morris International Inc | 1,318 | $218K |
| AZNASTRAZENECA PLC | 1,098 | $217K |
| OPKOPKO HEALTH, INC. | 66,490 | $76K |
| PLXProtalix BioTherapeutics, Inc. | 12,000 | $26K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.